GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide that has attracted interest in skin biology, tissue remodeling, wound-related research, and cosmetic skincare.
Also known as: Copper tripeptide-1, Copper peptide, Glycyl-L-histidyl-L-lysine copper
At a Glance
GHK-Cu is a naturally occurring copper-binding tripeptide that has attracted interest in skin biology, tissue remodeling, wound-related research, and cosmetic skincare.
Common Areas of Interest
Commonly discussed or studied in relation to:
Why People Are Interested
GHK-Cu has become well known in cosmetic skincare and longevity communities because copper peptides are involved in biological processes related to tissue remodeling and repair. Interest ranges from topical cosmetic products to experimental uses, but evidence should be interpreted separately for each formulation and route.
Evidence snapshot
Research supports biological activity relevant to tissue remodeling, and some human research has evaluated topical copper-peptide products. Evidence for broad systemic anti-aging claims is much less established. Evidence for a topical cosmetic product should not automatically be applied to injectable or systemic use.
- Type of evidence
- Laboratory, preclinical, and limited human clinical research
- Evidence level
- Human evidence available, but application-specific
Evidence level describes the maturity and type of available research. It does not determine whether a treatment is appropriate for an individual.
Hype vs. Evidence
A calm way to separate popular online claims from what research currently supports.
What You May Hear
Copper peptide is a powerful anti-aging peptide that can rejuvenate the body and skin.
What the Evidence Supports
GHK-Cu has biologically plausible effects and research relevant to skin and tissue remodeling, with some human topical research.
What's Still Unknown
Broad systemic anti-aging and longevity claims have not been established by high-quality clinical evidence.
Regulatory / research status
GHK-Cu appears in FDA compounding-related materials. FDA has specifically identified safety concerns for compounded injectable GHK-Cu, including potential immunogenicity associated with aggregation and peptide-related impurities, and notes limited human safety data for injectable use. Non-injectable GHK-Cu has been handled separately in FDA's compounding review process.
Approval for one specific indication never implies approval or suitability for wellness, cosmetic, or anti-aging uses.
What We Know
GHK-Cu binds copper and has biological activity relevant to tissue remodeling. Topical copper-peptide products have been investigated in human skin-related settings.
What We Don't Know Yet
Strong clinical evidence demonstrating broad systemic rejuvenation, longevity, or whole-body anti-aging effects in humans is lacking. Safety and effectiveness can differ substantially by formulation and route.
Important Considerations
Do not treat evidence from topical cosmetic use as evidence for injectable use. Route, formulation, purity, and intended use matter.
Questions for Your Healthcare Provider
- What evidence exists for the specific GHK-Cu formulation I am considering?
- Is the evidence topical, injectable, or from laboratory research?
- What human safety information exists for this route?
- Are there better-studied options for my particular goal?
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
U.S. Food and Drug Administration · FDA · Accessed August 31, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A
U.S. Food and Drug Administration · FDA · Accessed August 31, 2026
- Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Archives of Facial Plastic Surgery / PubMed · Peer-reviewed human study · 2006 · PMID 16847171 · Accessed August 31, 2026
Last reviewed: August 31, 2026
Peptide Explorer provides general educational information only and is not medical advice. It does not diagnose, treat, prevent, or cure any condition and does not recommend specific peptides, medications, products, doses, or treatment protocols. Research and regulatory status may change over time. Always discuss health decisions with an appropriately qualified healthcare professional.